Evaluation of the Effects of Insulin Peglispro (LY2605541) on Respiratory Quotient During Sleep and Response to Hyperinsulinemia Compared With That of Insulin Glargine in Patients With Type 1 Diabetes Mellitus
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Insulin peglispro (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 08 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Feb 2015 Planned End Date changed from 1 Mar 2015 to 1 Oct 2015 as reported by ClinicalTrials.gov
- 09 Feb 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Oct 2015 as reported by ClinicalTrials.gov